Advertisement
News
Subscribe to MDT Magazine News

Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem

February 18, 2011 7:34 am | by Bio-Medicine.Org | Comments

MEMPHIS, Tenn., Feb. 18, 2011 /- At this week's annual meeting of the American Academy of Orthopedic Surgeons, Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedic Division introduced its Short Modular Femoral (SMF™) Hip System, a modular total hip replacement stem system that...

TOPICS:

LifePoint Hospitals 4Q profit slips 5 percent

February 18, 2011 6:45 am | by The Associated Press | Comments

LifePoint Hospitals Inc. said Friday its fourth quarter profit fell 5 percent as some expenses climbed, and the rural hospital operator saw drops in admissions and surgeries performed at locations it operated over the past year.Chairman and CEO William F. Carpenter III said in a statement the...

Insurer UnitedHealthcare to expand Va. operations

February 18, 2011 6:45 am | by The Associated Press | Comments

Insurer UnitedHealthcare is planning to expand its operations in Roanoke, Va., creating 125 jobs over the next two years.Gov. Bob McDonnell's office said Friday that the multimillion-dollar investment will expand and upgrade UnitedHealthcare's leased office space. Improvements are expected to...

Advertisement

Penn Doctors Certified in New Advanced Heart Failure and Transplant Cardiology Specialty

February 18, 2011 6:33 am | by University Of Pennsylvania | Comments

Penn Medicine cardiologists are leaders in a new cardiology subspecialty, Advanced Heart Failure and Transplant Cardiology. Seven of the nine Heart Failure and Transplant doctors at Penn are now certified by the American Board of Internal Medicine (ABIM) in the new Advanced Heart Failure...

TOPICS:

TomoTherapy reports larger loss on service costs

February 18, 2011 5:45 am | by The Associated Press | Comments

Cancer treatment system maker TomoTherapy Inc. reported a larger fourth-quarter loss on Friday as its service and other costs increased.TomoTherapy makes radiation systems designed to target tumors while reducing exposure to surrounding healthy tissue.The company reported a net loss of $6.4...

Alere charge leads to $1B Q4 loss

February 18, 2011 5:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Alere Inc., the Waltham-based maker of consumer-focused health technologies formerly known as Inverness Medical Innovations Inc., reported it took a $1 billion hit in the fourth quarter of 2010 related to its Health Management business segment.

IBM, Nuance adding Watson to health-care text team-up

February 18, 2011 5:36 am | by Mass High Tech: The Journal of New England Technology | Comments

One day after IBM Corp.'s trivia-playing supercomputer Watson trounced his human opponents on Jepoardy!, IBM and Nuance Communications Inc. announced a deal to bring speech recognition to Watson for its possible first real-world use in the health-care industry.

American Scientific Resources Announces New Distributor HospiServices Placing Kidz-Med VeraTemp in Middle Eastern and African Pharmacies

February 18, 2011 5:35 am | by Bio-Medicine.Org | Comments

WESTON, Fla., Feb. 18, 2011 /- American Scientific Resources, Inc. (Pink Sheets: ASFX ) announces Lebanon-based HospiServices is the Company's new distributor in the Middle East and Africa. HospiServices has placed its second order totaling 684 units for the Kidz-Med line of VeraTemp...

TOPICS:
Advertisement

Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call

February 18, 2011 5:33 am | by Bio-Medicine.Org | Comments

CARY, N.C., Feb. 18, 2011 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) today announced that it will host a conference call at 8:30 AM ET on Thursday, March 3, 2011, to discuss its financial results for the quarter and twelve months ended December 31, 2010. Financial results are...

TOPICS:

Two Knee Replacements May Be Better Than One

February 18, 2011 5:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 18, 2011 /PRNewswire-USNewswire/ -- Replacing both knees in one surgery, or simultaneous total knee replacement (TKR) was associated with significantly fewer prosthetic joint infections as well as other revision knee operations within one year after surgery, compared with...

TOPICS:

Medco Health will report 4Q results Tuesday(2)

February 18, 2011 4:46 am | by The Associated Press | Comments

Pharmacy benefits manager Medco Health Solutions Inc. reports its fourth-quarter results before the stock market opens Tuesday.WHAT TO WATCH FOR: Medco manages prescription drug benefits for health plan sponsors and members. Wall Street will be watching the company's success at winning new...

Medco Health will report 4Q results Tuesday

February 18, 2011 4:45 am | Comments

Pharmacy benefits manager Medco Health Solutions Inc. reports its fourth-quarter results before the stock market opens Tuesday.WHAT TO WATCH FOR: Medco manages prescription drug benefits for health plan sponsors and members. Wall Street will be watching the company's success at winning new...

Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe

February 18, 2011 3:38 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., Feb. 18, 2011 /- Life Technologies Corporation (Nasdaq: LIFE ), today announced Dr. Angel Carracedo and Dr. Mark Pallen as the winners of the European Ion Torrent Personal Genome Machine (PGM™) Sequencer Grants Program.   (Logo:  ...

TOPICS:

Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine

February 18, 2011 3:38 am | by Bio-Medicine.Org | Comments

ORLANDO, Fla., Feb. 18, 2011 /- Bellicum Pharmaceuticals, Inc. today announced the presentation of Phase I/II safety and efficacy data for BPX-101, a novel drug-activated dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in three separate posters at the...

TOPICS:

NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting

February 18, 2011 3:37 am | by Bio-Medicine.Org | Comments

ROCKVILLE, Md., Feb. 18, 2011 /- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biopharmaceutical company, today presented the final safety and immunogenicity results from its 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine clinical trial in Mexico at the invitation-only 7th...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading